-
Fund Dashboard
- Holdings
AlphaCentric LifeSci Healthcare Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
FIRST AM-TR OB-X | 7.32 mm | 7.32 mm principal | 8.83 | Short-term investment vehicle | Long | USA |
HRMY Harmony Biosciences Holdings, Inc. | 3.88 mm | 97.00 k shares | 4.68 | Common equity | Long | USA |
GALAPAGOS NV-ADR
|
3.12 mm | 108.50 k shares | 3.77 | Common equity | Long | Belgium |
MRK Merck & Co., Inc. | 2.73 mm | 24.00 k shares | 3.29 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 2.59 mm | 22.50 k shares | 3.13 | Common equity | Long | USA |
ARGX argenx SE | 2.44 mm | 4.50 k shares | 2.94 | Common equity | Long | Netherlands |
INDV Indivior PLC | 2.36 mm | 242.50 k shares | 2.85 | Common equity | Long | UK |
BMRN BioMarin Pharmaceutical Inc. | 2.28 mm | 32.50 k shares | 2.76 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 2.25 mm | 18.00 k shares | 2.71 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 2.24 mm | 201.50 k shares | 2.71 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 2.24 mm | 6.25 k shares | 2.70 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 2.19 mm | 205.00 k shares | 2.64 | Common equity | Long | USA |
ATEC Alphatec Holdings, Inc. | 2.06 mm | 370.00 k shares | 2.48 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 2.04 mm | 30.00 k shares | 2.46 | Common equity | Long | USA |
RPRX Royalty Pharma plc | 1.91 mm | 67.50 k shares | 2.30 | Common equity | Long | UK |
MIRM Mirum Pharmaceuticals, Inc. | 1.76 mm | 45.00 k shares | 2.12 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 1.73 mm | 15.50 k shares | 2.08 | Common equity | Long | Ireland |
ITCI Intra-Cellular Therapies, Inc. | 1.46 mm | 20.00 k shares | 1.76 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals, Inc. | 1.46 mm | 30.00 k shares | 1.76 | Common equity | Long | USA |
VRNA Verona Pharma plc | 1.44 mm | 50.00 k shares | 1.73 | Common equity | Long | UK |
GSK GSK plc | 1.43 mm | 35.00 k shares | 1.73 | Common equity | Long | UK |
APLS Apellis Pharmaceuticals, Inc. | 1.37 mm | 47.50 k shares | 1.65 | Common equity | Long | USA |
RVNC Revance Therapeutics, Inc. | 1.27 mm | 245.00 k shares | 1.53 | Common equity | Long | USA |
BGNE BeiGene, Ltd. | 1.23 mm | 5.50 k shares | 1.49 | Common equity | Long | Cayman Islands |
ENOV Enovis Corporation | 1.18 mm | 27.50 k shares | 1.43 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd. | 1.15 mm | 100.00 k shares | 1.39 | Common equity | Long | Bermuda |
GPCR Structure Therapeutics Inc. | 1.14 mm | 26.00 k shares | 1.38 | Common equity | Long | Cayman Islands |
TAK Takeda Pharmaceutical Company Limited | 1.14 mm | 80.00 k shares | 1.37 | Common equity | Long | Japan |
PTGX Protagonist Therapeutics, Inc. | 1.13 mm | 25.00 k shares | 1.36 | Common equity | Long | USA |
LNTH Lantheus Holdings, Inc. | 1.07 mm | 80.00 k shares | 1.29 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 1.02 mm | 30.00 k shares | 1.23 | Common equity | Long | USA |
PFE Pfizer Inc. | 1.01 mm | 35.00 k shares | 1.22 | Common equity | Long | USA |
SNY Sanofi | 1.01 mm | 17.50 k shares | 1.22 | Common equity | Long | France |
IMVT Immunovant, Inc. | 997.85 k | 35.00 k shares | 1.20 | Common equity | Long | USA |
LANTHEUS HOLDING
|
987.75 k | 9.00 k shares | 1.19 | Common equity | Long | USA |
ALPMY Astellas Pharma Inc. | 973.25 k | 85.00 k shares | 1.17 | Common equity | Long | Japan |
AXSM Axsome Therapeutics, Inc. | 943.64 k | 10.50 k shares | 1.14 | Common equity | Long | USA |
KPTI Karyopharm Therapeutics Inc. | 933.75 k | 1.13 mm shares | 1.13 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 848.63 k | 37.50 k shares | 1.02 | Common equity | Long | UK |
PEN Penumbra, Inc. | 777.24 k | 4.00 k shares | 0.94 | Common equity | Long | USA |
VALN Valneva SE | 717.44 k | 118.00 k shares | 0.87 | Common equity | Long | France |
NUVL Nuvalent, Inc. | 716.10 k | 7.00 k shares | 0.86 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics | 705.88 k | 14.00 k shares | 0.85 | Common equity | Long | Cayman Islands |
CYTK Cytokinetics, Incorporated | 660.00 k | 12.50 k shares | 0.80 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 615.20 k | 40.00 k shares | 0.74 | Common equity | Long | USA |
SGMT Sagimet Biosciences Inc. | 512.45 k | 185.00 k shares | 0.62 | Common equity | Long | USA |
EMBC Embecta Corp. | 507.60 k | 36.00 k shares | 0.61 | Common equity | Long | USA |
VYNE VYNE Therapeutics Inc. | 504.75 k | 268.49 k shares | 0.61 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 499.29 k | 8.50 k shares | 0.60 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 464.56 k | 8.00 k shares | 0.56 | Common equity | Long | USA |
MDT Medtronic plc | 450.15 k | 5.00 k shares | 0.54 | Common equity | Long | Ireland |
INSM Insmed Incorporated | 365.00 k | 5.00 k shares | 0.44 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 359.20 k | 10.00 k shares | 0.43 | Common equity | Long | USA |
AVBP ArriVent BioPharma, Inc. Common Stock | 352.50 k | 15.00 k shares | 0.43 | Common equity | Long | USA |
CHRS Coherus BioSciences, Inc. | 343.20 k | 330.00 k shares | 0.41 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 341.25 k | 15.00 k shares | 0.41 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 331.50 k | 7.50 k shares | 0.40 | Common equity | Long | USA |
JSPR Jasper Therapeutics, Inc. | 329.18 k | 17.50 k shares | 0.40 | Common equity | Long | USA |
NUVB Nuvation Bio Inc. | 309.15 k | 135.00 k shares | 0.37 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 293.44 k | 3.50 k shares | 0.35 | Common equity | Long | USA |
KNSA Kiniksa Pharmaceuticals, Ltd. | 286.84 k | 11.48 k shares | 0.35 | Common equity | Long | UK |
IMTX Immatics N.V. | 285.25 k | 25.00 k shares | 0.34 | Common equity | Long | Netherlands |
DXCM DexCom, Inc. | 279.62 k | 4.17 k shares | 0.34 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 221.59 k | 3.50 k shares | 0.27 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 141.41 k | 5.50 k shares | 0.17 | Common equity | Long | USA |
PGNY Progyny, Inc. | 125.70 k | 7.50 k shares | 0.15 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 37.73 k | 1.00 k shares | 0.05 | Common equity | Long | USA |
FID-MM GOVT-I | 1.46 | 1.46 principal | 0.00 | Short-term investment vehicle | Long | USA |